These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2186418)

  • 21. Anxiety, cognition, and habit: a multiple memory systems perspective.
    Packard MG
    Brain Res; 2009 Oct; 1293():121-8. PubMed ID: 19328775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
    Goekoop R; Scheltens P; Barkhof F; Rombouts SA
    Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptides in learning and memory processes with focus on galanin.
    Ogren SO; Kuteeva E; Elvander-Tottie E; Hökfelt T
    Eur J Pharmacol; 2010 Jan; 626(1):9-17. PubMed ID: 19837050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NGF and the treatment of Alzheimer's disease.
    Olson L
    Exp Neurol; 1993 Nov; 124(1):5-15. PubMed ID: 8282080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotransmitter receptors in Alzheimer disease.
    Greenamyre JT; Maragos WF
    Cerebrovasc Brain Metab Rev; 1993; 5(2):61-94. PubMed ID: 8392361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories.
    de Jongh R; Bolt I; Schermer M; Olivier B
    Neurosci Biobehav Rev; 2008; 32(4):760-76. PubMed ID: 18295885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reasons for prescribing cognition enhancers in primary care. Results of a representative survey in Lower Saxony, Germany.
    Stoppe G; Sandholzer H; Staedt J; Winter S; Kiefer J; Rüther E
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):486-90. PubMed ID: 8520805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen and cognition, with a focus on Alzheimer's disease.
    Pinkerton JV; Henderson VW
    Semin Reprod Med; 2005 May; 23(2):172-9. PubMed ID: 15852203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Problems in the search for cognition enhancers.
    Hollister LE
    Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():33-6. PubMed ID: 2186410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurotransmitters in Alzheimer's disease].
    Kristensen MO
    Ugeskr Laeger; 1990 Jul; 152(30):2165-8. PubMed ID: 1975961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.
    Berridge CW; Devilbiss DM; Andrzejewski ME; Arnsten AF; Kelley AE; Schmeichel B; Hamilton C; Spencer RC
    Biol Psychiatry; 2006 Nov; 60(10):1111-20. PubMed ID: 16806100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the CREB pathway for memory enhancers.
    Tully T; Bourtchouladze R; Scott R; Tallman J
    Nat Rev Drug Discov; 2003 Apr; 2(4):267-77. PubMed ID: 12669026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How do neuropeptides alter cognitive performance?
    Sahgal A
    Pol J Pharmacol Pharm; 1990; 42(6):527-35. PubMed ID: 2103004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memory, thinking, and aging. What we know about what we know.
    Teri L; McCurry SM; Logsdon RG
    West J Med; 1997 Oct; 167(4):269-75. PubMed ID: 9348759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological actions of Thespesia populnea relevant to Alzheimer's disease.
    Vasudevan M; Parle M
    Phytomedicine; 2006 Nov; 13(9-10):677-87. PubMed ID: 16860552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive enhancing agents: current status in the treatment of Alzheimer's disease.
    Waters C
    Can J Neurol Sci; 1988 Aug; 15(3):249-56. PubMed ID: 3061625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers.
    Wenk GL
    Psychopharmacology (Berl); 1989; 99(4):431-8. PubMed ID: 2687922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taking stock of cognition enhancers.
    Sarter M
    Trends Pharmacol Sci; 1991 Dec; 12(12):456-61. PubMed ID: 1792689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbial manipulation of memories and minds.
    Gubert C; Hannan AJ
    Brain; 2023 Dec; 146(12):4791-4793. PubMed ID: 37873966
    [No Abstract]   [Full Text] [Related]  

  • 40. Cognition as search.
    Feldman JA
    Science; 1991 Feb; 251(4993):575. PubMed ID: 17840870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.